Cinctive Capital Management LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cinctive Capital Management LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,249,000
-3.4%
41,073
-2.9%
0.05%
+8.3%
Q1 2022$1,293,000
-2.2%
42,3030.0%0.05%
-17.2%
Q4 2021$1,322,000
+15.4%
42,303
-43.6%
0.06%
+3.6%
Q3 2021$1,146,00075,0000.06%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders